← Back to Search

Patient Navigator for Metabolic Diseases (TNT Trial)

N/A
Waitlist Available
Led By Gina Dimitropoulos, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 to 24 months
Awards & highlights

TNT Trial Summary

This trial will help guide how best to provide care for adolescents with chronic health conditions as they transition to adulthood.

Eligible Conditions
  • Metabolic Diseases
  • Autism Spectrum Disorder
  • Epilepsy
  • Kidney Disease
  • Cardiovascular Disease
  • Gastrointestinal Disorder
  • Fetal Alcohol Spectrum Disorders
  • Autism
  • Respiratory Diseases
  • Neurodegenerative Disease
  • Autoimmune Diseases
  • Genetic Disorders
  • Diabetes
  • Endocrine Disorders
  • Blood Diseases
  • Traumatic Brain Injury
  • Stroke

TNT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Health services utilization
Secondary outcome measures
Variation in SF-12 Scores
Variation in TRAQ (Transition Readiness Questionnaire) scores
cost analysis
Other outcome measures
Youth/Caregiver Satisfaction

TNT Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual Care ArmExperimental Treatment1 Intervention
Youth will receive usual care from their pediatric clinics in preparation and transfer to adult care. Participants will receive 5 issues of a provincial generic newsletter on topics around transition. Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months. Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months. Participants will be provided the opportunity to journal online about their experiences.
Group II: Patient Navigator ArmExperimental Treatment1 Intervention
Patient Navigator (Social Worker) will assist youth adapt and attach to adult delivered healthcare for up to 24 months. Participants will receive 5 issues of a provincial generic newsletter on topics around transition. Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months. Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months. Participants will be provided the opportunity to journal online about their experiences. Up to 100 participants will be provided the opportunity to be interviewed at baseline and end of study about their transition experience.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
791 Previous Clinical Trials
868,397 Total Patients Enrolled
4 Trials studying Metabolic Diseases
386 Patients Enrolled for Metabolic Diseases
University of AlbertaOTHER
886 Previous Clinical Trials
384,441 Total Patients Enrolled
4 Trials studying Metabolic Diseases
390 Patients Enrolled for Metabolic Diseases
Alberta Health servicesOTHER
157 Previous Clinical Trials
649,207 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals 45 years or older being accepted into this experiment?

"According to the requirements, individuals between 16 and 21 years old are eligible for this clinical trial. Meanwhile, 883 trials cater to minors while 3191 study options exist for seniors aged 65 or older."

Answered by AI

Are there any available slots for participants in this clinical trial?

"According to clinicaltrials.gov, this trial has ceased recruiting patients and the last update was on September 22nd 2021. Despite its inactivity, there are still 4116 other trials actively seeking participants for their studies."

Answered by AI

Do I meet the requirements to take part in this experiment?

"This study is searching for 337 individuals aged 16 to 21 who possess an inherited disorder. To qualify, these people must have a chronic illness lasting more than 3 months or that affects multiple organs/systems and should be expecting transferral to adult medical care within 12 months of the assessment criteria being met."

Answered by AI

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
BMJ OpenJournal
Pragmatic Trial Evaluating the Effectiveness of a Patient Navigator to Decrease Emergency Room Utilisation in Transition Age Youth with Chronic Conditions: The Transition Navigator Trial Protocol
Samuel, Susan, Gina Dimitropoulos, Kyleigh Schraeder, Scott Klarenbach, Alberto Nettel-Aguirre, Greg Guilcher, Daniele Pacaud, et al.. 2019. “Pragmatic Trial Evaluating the Effectiveness of a Patient Navigator to Decrease Emergency Room Utilisation in Transition Age Youth with Chronic Conditions: The Transition Navigator Trial Protocol”. BMJ Open. BMJ. doi:10.1136/bmjopen-2019-034309.
clinicaltrials.govStudy
Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial
2018. "Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03342495.
~47 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top